m+Medelevator.RU
← Поиск публикаций
ACS applied materials & interfaces · 2026

Sprayable Integrated Hydrogel for Synergistic Alleviation of Oxidative Stress in Atopic Dermatitis Treatment.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Liu Shuang, Zhou Xiao, Tang Huacheng, Wang Ying, Li Yingxi, Duan Yun, He Yaxuan, Su Shengxin, Jiang Fuchen, Huang Zhen, Lai Xiaomin, Lu Jun, Pan Xiaoli

Аннотация

Atopic dermatitis (AD) is a chronic inflammatory skin disorder whose pathogenesis is primarily associated with impaired skin barrier function and abnormal immune responses. Oxidative stress is a key factor exacerbating inflammation and itching. To address the challenge that existing local therapies struggle to sustainably regulate redox balance in the microenvironment, this study cross-linked carboxymethylated housefly chitosan (CMCS) with oxidized fucoidan (OFUA) to form an imine-linked hydrogel (C/O) via a Schiff base reaction and loaded it with a functionalized nanoparticle. This nanoparticle was a cyclodextrin metal-organic framework (P-M@CA) loaded with chlorogenic acid (CA) and surface-modified with polydopamine (PDA). A composite hydrogel system (C/O/P) for AD treatment was successfully constructed. This system exhibited strong antioxidant activity both in vitro and in vivo and effectively alleviated oxidative stress associated with AD. The C/O/P hydrogel dramatically decreased epidermal thickening, inhibited mast cell infiltration, downregulated the key inflammatory factor thymic stromal lymphopoietin (TSLP), and lowered serum immunoglobulin E (IgE) levels in an AD mouse model established by induction with 1-chloro-2,4-dinitrobenzene (DNCB). In summary, C/O/P hydrogels effectively clear reactive oxygen species and regulate the oxidative stress microenvironment, offering a promising local delivery strategy for AD treatment.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты